Literature DB >> 33615335

Long-term Outcomes of Ophthalmic and Retinal Artery Occlusion After Cosmetic Facial Filler Injection.

Yun Jeong Lee1, Se Joon Woo2.   

Abstract

BACKGROUND: Ophthalmic artery occlusion (OAO) and retinal artery occlusion (RAO) after facial filler injection have become increasingly significant due to the growth in cosmetic injection procedures for aesthetic purposes.
OBJECTIVES: The aim of this study was to analyze the long-term visual outcomes and complications of cosmetic facial filler-related OAO and RAO.
METHODS: This single-center, retrospective case series included 17 eyes of 16 filler-related OAO or RAO patients with a follow-up period of 1 year or longer. Main outcome measures were best-corrected visual acuity (BCVA) and long-term complications.
RESULTS: The mean [standard deviation] age at diagnosis was 31.7 [9.7] years; all the patients were female. The mean follow-up period was 5.4 [2.4] years. The mean BCVA was 2.34 and 2.41 logMAR at the initial and final visits, respectively, which indicates sustained long-term visual impairment. Ocular complications included retinal atrophy and degeneration (100.0%), optic atrophy and blindess (no light perception) (82.4%), strabismus (80.0%), retinal fibrous membrane (68.8%), posterior synechiae (35.3%), neovascularization (29.4%), iris atrophy and cataract (23.5%), corneal opacity and phthisis bulbi (17.6%), visual field defect and iris defect (11.8%), ophthalmoplegia (7.7%), and pupillary block (5.9%). Extraocular complications of brain infarction and depression were found in 25.0%, whereas skin necrosis was found in 13.3% of patients.
CONCLUSIONS: Facial filler-related OAO or RAO resulted in long-term poor visual outcome, and most of the patients experienced irreversible visual impairment with no light perception despite various treatments. Various long-term ocular and extraocular complications were observed, which should be monitored for a long-term follow-up period. Our findings suggest that prevention should be emphasized more than treatment.
© 2021 The Aesthetic Society. Reprints and permission: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2022        PMID: 33615335     DOI: 10.1093/asj/sjab099

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  2 in total

1.  Superselective Ophthalmic Artery Thrombolytic Therapy for Hyaluronic Acid Embolization: A Case Report.

Authors:  Qian Wu; Qiang Fu; Xiao Xu; Can Zheng; Jie Zhang; Minliang Chen
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-01

2.  Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections.

Authors:  Bilgen Can
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.